First-line obinutuzumab for follicular lymphoma

被引：0
|
作者：
Baker, Holly
机构：
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 11期
关键词：
D O I：
10.1016/S1470-2045(17)30781-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E648 / E648
页数：1
相关论文
共 50 条
  • [1] Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
    Marcus, R.
    Davies, A.
    Ando, K.
    Klapper, W.
    Opat, S.
    Owen, C.
    Phillips, E.
    Sangha, R.
    Schlag, R.
    Seymour, J. F.
    Townsend, W.
    Trneny, M.
    Wenger, M.
    Fingerle-Rowson, G.
    Rufibach, K.
    Moore, T.
    Herold, M.
    Hiddemann, W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14): : 1331 - 1344
  • [2] The societal impact of obinutuzumab in the first-line treatment of patients with follicular lymphoma in Germany
    Hofmann, Sarah
    Himmler, Sebastian
    Ostwald, Dennis
    Duenzinger, Ulrich
    Launonen, Aino
    Thuresson, Per-Olof
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (14) : 1017 - 1026
  • [3] Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma
    Gwladys Claustre
    Coralie Boulanger
    Frédéric Maloisel
    Nelly Etienne-Selloum
    Luc-Matthieu Fornecker
    Eric Durot
    Florian Slimano
    Véronique Graff
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 1883 - 1893
  • [4] Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma
    Claustre, Gwladys
    Boulanger, Coralie
    Maloisel, Frederic
    Etienne-Selloum, Nelly
    Fornecker, Luc-Matthieu
    Durot, Eric
    Slimano, Florian
    Graff, Veronique
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (05) : 1883 - 1893
  • [5] Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first-line immunochemotherapy
    Jamois, Candice
    Gibiansky, Ekaterina
    Gibiansky, Leonid
    Buchheit, Vincent
    Sahin, Denis
    Cartron, Guillaume
    Marcus, Robert
    Hiddemann, Wolfgang
    Seymour, John F.
    Strefford, Jonathan C.
    Hargreaves, Chantal E.
    Meneses-Lorente, Georgina
    Frey, Nicolas
    Fingerle-Rowson, Guenter
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (07) : 1495 - 1506
  • [6] First-Line Management of Follicular Lymphoma
    Marcus, Robert
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S83 - S85
  • [7] Management of patients with follicular lymphoma treated first line with obinutuzumab
    Opat, Stephen
    Dickinson, Michael
    Cheah, Chan Yoon
    Tam, Constantine
    Boulos, Joy
    Thorburn, Alison Nicole
    Trotman, Judith
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 3 - 11
  • [8] Follicular Lymphoma: First-Line Treatment Without Chemotherapy for Follicular Lymphoma
    Reagan, Patrick M.
    Friedberg, Jonathan W.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (07)
  • [9] Follicular Lymphoma: First-Line Treatment Without Chemotherapy for Follicular Lymphoma
    Patrick M. Reagan
    Jonathan W. Friedberg
    Current Treatment Options in Oncology, 2015, 16
  • [10] THE SOCIETAL IMPACT OF OBINUTUZUMAB IN THE FIRST LINE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA IN GERMANY
    Hofmann, S.
    Ostwald, D. A.
    Himmler, S.
    Launonen, A.
    Duenzinger, U.
    Salmen, H.
    VALUE IN HEALTH, 2018, 21 : S37 - S37
12345